病例报告:使用剂量密集化疗完全缓解胸腺癌
Mae Shu1, Tieying Hou2, Stacy M Rissing3
1Indiana University School of Medicine, Indianapolis, IN, United States.
Frontiers in oncology
|March 16, 2026
概括
剂量密集的化疗在治疗晚期胸腺癌方面表现出显著的疗效,导致一名患者的完整病理反应. 这种方法可能为管理这些罕见但具有挑战性的中间体恶性瘤提供了一个有希望的新策略.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 医学瘤学 医学瘤学
背景情况:
- 胸膜上皮瘤 (胸膜瘤,胸膜癌) 是一种罕见的中瘤.
- 晚期阶段往往带来不良的长期结果.
- 目前的治疗方法包括手术和基于的化疗,进展有限.
研究的目的:
- 报告一个晚期胸腺癌的病例,该病例对高剂量化疗有反应.
- 突出剂量密集化疗在胸膜恶性瘤中的潜力.
主要方法:
- 一名患有晚期激素受体阳性/HER2阳性乳腺癌和同步晚期胸膜癌的患者接受了剂量密集的化疗.
- 通过间隔成像和随后的手术切除来评估反应.
主要成果:
- 患者在剂量密集的化疗后实现了胸腺癌的完整病理反应.
- 在复发前四年观察到无病生存期.
结论:
- 在这种情况下,剂量密集的化疗证明了对晚期胸膜癌的显著有效性.
- 这种疗法可能是胸膜恶性瘤的有希望的治疗选择,需要进一步研究.
相关概念视频
02:56Treatment Resistent Cancers
1.5K
1.5K
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K